Research map: Exploration of the Pathogenesis and Treatment of Heart Failure
Back to the article
Papers in this map
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure · Theresa A. McDonagh · 2021 · 13611 citations · Cited by this paper
- Predictors of Outcomes in Patients With Clinically Suspected Myocarditis: Analysis From a Single Center Registry · 2026 · Related
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease · Paul M. Ridker · 2017 · 9543 citations · Cited by this paper
- Bayes Syndrome and Myocardial Fibrosis: Mechanistic Links and Clinical Implications · 2026 · Related
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction · John J.V. McMurray · 2019 · 7146 citations · Cited by this paper
- Potential Relationship Between Ferroptosis and Pyroptosis in Myocardial Ischemia/Reperfusion Injury: Molecular Mechanisms and Therapeutic Targets · 2026 · Related
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction · Stefan D. Anker · 2021 · 4865 citations · Cited by this paper
- Cost Impact of a Coronary Computed Tomography Angiography-Based Diagnostic Pathway for Low-Risk Chest Pain in the Emergency Department · 2026 · Related
- Cardiac excitation–contraction coupling · Donald M. Bers · 2002 · 4809 citations · Cited by this paper
- Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease? · 2026 · Related
- Global burden of heart failure: a comprehensive and updated review of epidemiology · Gianluigi Savarese · 2022 · 3331 citations · Cited by this paper
- Cardiovascular Toxicity of BTKi in Chronic B-Cell Malignancies · 2026 · Related
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction · Jean‐Claude Tardif · 2019 · 3144 citations · Cited by this paper
- Poor Distal Left Atrial Appendage Opacification on Early-Phase Cardiac CTA and Association With Arterial Thromboembolism · 2026 · Related
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction · Scott David Solomon · 2022 · 2871 citations · Cited by this paper
- Pericardial Diseases in Cardiovascular Medicine: Contemporary Diagnosis, Risk Stratification, Multimodality Imaging, and Targeted Anti-Inflammatory Therapy · 2026 · Related
- 2023 ESC Guidelines for the management of cardiomyopathies · Elena Arbelo · 2023 · 2720 citations · Cited by this paper
- Prophylactic Methylprednisolone in Neonatal On-Pump Cardiac Surgery · 2026 · Related
- 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure · Theresa A. McDonagh · 2023 · 2438 citations · Cited by this paper
- Comparative Efficacy of Integrated Stent-Graft versus Conventional Covered Stent-Graft Alone in Type B Aortic Dissection: A Retrospective Study Focusing on Aortic Remodeling and Branch Perfusion · 2026 · Related
- Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system · Puja K. Mehta · 2006 · 1930 citations · Cited by this paper
- Diabetic Cardiomyopathy · Guanghong Jia · 2018 · 1876 citations · Cited by this paper
- Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure · Biykem Bozkurt · 2021 · 1648 citations · Cited by this paper
- Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity · Mikhail Kosiborod · 2023 · 1621 citations · Cited by this paper
- Mechanisms and Models in Heart Failure · Douglas L. Mann · 2005 · 875 citations · Cited by this paper
- Dietary metabolism, the gut microbiome, and heart failure · W.H. Wilson Tang · 2018 · 812 citations · Cited by this paper
- Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes · Mikhail Kosiborod · 2024 · 722 citations · Cited by this paper
- Neurohormonal activation in heart failure with reduced ejection fraction · Justin C. Hartupee · 2016 · 719 citations · Cited by this paper
- Heart Failure With Preserved Ejection Fraction · Barry A. Borlaug · 2023 · 708 citations · Cited by this paper
- Altered Intestinal Function in Patients With Chronic Heart Failure · Anja Sandek · 2007 · 664 citations · Cited by this paper
- Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers · Ingrid A.W. van Rijsingen · 2012 · 537 citations · Cited by this paper
- Global epidemiology of heart failure · Muhammad Shahzeb Khan · 2024 · 531 citations · Cited by this paper
- Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference · Andrew A. House · 2019 · 457 citations · Cited by this paper
- Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial · JoAnn M. Lindenfeld · 2021 · 437 citations · Cited by this paper
- Right Heart Dysfunction and Failure in Heart Failure with Preserved Ejection Fraction: Mechanisms and Management. Position Statement on Behalf of the Heart Failure Association of the European Society of Cardiology · Thomas M. Gorter · 2017 · 388 citations · Cited by this paper
- Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials · Javed Butler · 2024 · 367 citations · Cited by this paper
- Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure · Benjamin Wallace Van Tassell · 2017 · 246 citations · Cited by this paper
- Vasopressin Antagonism in Heart Failure · Steven R. Goldsmith · 2005 · 224 citations · Cited by this paper
- Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure · George F. Wohlford · 2020 · 178 citations · Cited by this paper
Source: OpenAlex (CC0)